The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteTox.

ACuteTox is a project within the 6th European Framework Programme which had as one of its goals to develop, optimise and prevalidate a non-animal testing strategy for predicting human acute oral toxicity. In its last 6 months, a challenging exercise was conducted to assess the predictive capacity of the developed testing strategies and final identification of the most promising ones. Thirty-two chemicals were tested blind in the battery of in vitro and in silico methods selected during the first phase of the project. This paper describes the classification approaches studied: single step procedures and two step tiered testing strategies. In summary, four in vitro testing strategies were proposed as best performing in terms of predictive capacity with respect to the European acute oral toxicity classification. In addition, a heuristic testing strategy is suggested that combines the prediction results gained from the neutral red uptake assay performed in 3T3 cells, with information on neurotoxicity alerts identified by the primary rat brain aggregates test method. Octanol-water partition coefficients and in silico prediction of intestinal absorption and blood-brain barrier passage are also considered. This approach allows to reduce the number of chemicals wrongly predicted as not classified (LD50>2000 mg/kg b.w.).

Théologie et bioéthique. Une perspective protestante

La contribution de l'éthique protestante au débat bioéthique est fortement dépendante de la situation confessionnelle des pays considérés. En Suisse, l'équilibre entre points de vue laïques, protestants et catholiques oblige à réfléchir à la condition pluraliste d'une éthique de la discussion de type démocratique. Les convictions protestantes y trouvent un terrain propice, dans le sens d'une éthique ouverte sur les représentations symboliques et religieuses dont la transcendance porte trace.

Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine.

Optimizing treatment goals in ulcerative colitis requires recognizing the needs of patients. It is increasingly recognized that adapting treatment strategies aligned with patient needs can improve patient compliance and consequently minimize relapse rates. Tailoring of treatment strategies can improve not only patient quality of life, and decrease the number harmed by adverse events from more potent drugs, but can also save valuable healthcare costs by avoiding high-cost treatment interventions associated with acute ulcerative colitis. This review will consider several elements of mesalazine management from the patient perspective based on a range of clinical and patient-focused evidence. By highlighting patient preferences in disease management it is envisaged that this review will aid physicians to optimize treatment decisions with the different mesalazine preparations available.

Cost evaluation of cardiac magnetic resonance imaging versus coronary angiography for the work-up of coronary artery disease

Background: CMR has recently emerged as a robust and reliable technique to assess coronary artery disease (CAD). A negative perfusion CMR test predicts low event rates of 0.3-0.5%/year. Invasive coronary angiography (CA) remains the "gold standard" for the evaluation of CAD in many countries.Objective: Assessing the costs of the two strategies in the European CMR registry for the work-up of known or suspected CAD from a health care payer perspective. Strategy 1) a CA to all patients or 2) a CA only to patients who are diagnosed positive for ischemia in a prior CMR.Method and results: Using data of the European CMR registry (20 hospitals, 11'040 consecutive patients) we calculated the proportion of patients who were diagnosed positive (20.6%), uncertain (6.5%), and negative (72.9%) after the CMR test in patients with known or suspected CAD (n=2'717). No other medical test was performed to patients who were negative for ischemia. Positive diagnosed patients had a coronary angiography. Those with uncertain diagnosis had additional tests (84.7%: stress echocardiography, 13.1%: CCT, 2.3% SPECT), these costs were added to the CMR strategy costs. Information from costs for tests in Germany and Switzerland were used. A sensibility analysis was performed for inpatient CA. For costs see figure. Results - costs.Discussion: The CMR strategy costs less than the CA strategy for the health insurance systems both, in Germany and Switzerland. While lower in costs, the CMR strategy is a non-invasive one, does not expose to radiation, and yields additional information on cardiac function, viability, valves, and great vessels. Developing the use of CMR instead of CA might imply some reduction in costs together with superior patient safety and comfort, and a better utilization of resources at the hospital level. Document introduit le : 01.12.2011

Institucions polítiques de Catalunya : creació de materials docents en suport digital que fomentin la interacció amb l'estudiant a partir de la visualització de conceptes

Amb una plantilla, hem elaborat uns materials docents -l'objecte d'estudi dels quals és l’Estatut d'Autonomia de Catalunya de 2006, des d'una perspectiva jurídica -, que corresponen fonamentalment a l’assignatura “Institucions Polítiques de Catalunya” de 4rt. curs de la llicenciatura de Dret de la UAB. Els materials s’han penjat al web http://www.institucionspolitiques.com. L' objectiu de l’acció docent ha estat consolidar una eina interactiva, que fomenti la creativitat i el treball cooperatiu de l’estudiant, que permeti un rol més actiu del professorat, i finalment, es faciliti l’adaptació docent a l’espai europeu d’educació superior. L’experiència s'ha completat amb l’ús del mètode bimodal -campus virtual de la UAB -, amb visites a institucions públiques i amb l’assistència periòdica com a públic a programes de televisió de continguts relacionats amb la matèria. La plantilla per a desenvolupar els diversos temes del programa ha estat la següent: 1.- Redacció del tema; 2.- Visualització de conceptes: quadres sinòptics, esquemes, gràfics; 3.-Bibliografia bàsica. 4.-Legislació i jurisprudència. 5.-Text reproduït. 6.-Qüestions.7.-Temes per al debat. 8.-Test. 9.-Materials complementaris audiovisuals. 10.-Enllaços útils a la xarxa. L'experiència s’ha desenvolupat els dos darrers cursos acadèmics: 2006/07 i 2007/08, i ha girat entorn de l'elaboració i aplicació dels materials elaborats. Ha estat teòrica i pràctica a la vegada. S'ha prestat especial atenció a la feina de l'alumnat fora de l'aula, amb el conseqüent estudi previ i col·laboració en l’elaboració de materials. Cal destacar també que hem aconseguit augmentar la participació de l'alumnat a l’aula, i d'aquesta manera el rol del professor ha esdevingut més dinàmic. Els materials han permès un fàcil i ràpid accés dels estudiants, amb l’objectiu de gaudir d’unes sessions presencials més interactives, i s'ha connectat la Universitat amb la societat, a més de desenvolupar actituds cíviques o de consciència de país en una matèria tan sensible com és l'estudi del dret públic de Catalunya.

Guidelines for the clinical management of atrial fibrillation: a practical perspective.

Since the management of atrial fibrillation may be difficult in the individual patient, our purpose was to develop simple clinical recommendations to help the general internist manage this common clinical problem. Systematic review of the literature with evaluation of data-related evidence and framing of graded recommendations. Atrial fibrillation affects some 1% of the population in Western countries and is linked to a significant increase in morbidity and mortality. The management of atrial fibrillation requires individualised evaluation of the risks and benefits of therapeutic modalities, relying whenever possible on simple and validated tools. The two main points requiring a decision in clinical management are 1) whether or not to implement thromboembolic prevention therapy, and 2) whether preference should be given to a "rate control" or "rhythm control" strategy. Thromboembolic prophylaxis should be prescribed after individualised risk assessment: for patients at risk, oral anticoagulation with warfarin decreases the rate of embolic complications by 60% and aspirin by 20%, at the expense of an increased incidence of haemorrhagic complications. "Rate control" and "rhythm control" strategies are probably equivalent, and the choice should also be made on an individualised basis. To assist the physician in making his choices for the care of an atrial fibrillation patient we propose specific tables and algorithms, with graded recommendations. On the evidence of data from the literature we propose simple algorithms and tables for the clinical management of atrial fibrillation in the individual patient.